Overview

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

Status:
Completed
Trial end date:
2019-10-21
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind clinical trial in a Chinese population.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin XinChen-Techfields Pharma Co., LTD.
Treatments:
Ibuprofen